An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
Clinical trial NCT05522387 · TERMINATED
Trial details
- NCT number
- NCT05522387
- Sponsor
- Inmune Bio, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-21
- Primary completion
- 2024-06-05
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.